Improving treatment retention for minority youth with depression or suicide risk
Official title: Strategic Treatment Assessment with Youth (STAY): A measurement-based care approach to promote treatment retention among racial and ethnic minoritized youth with depression or suicide risk
Funded at Yale University · NIH-11011441 · Data updated 2026-11-12
This study is looking to help young people from diverse backgrounds who are struggling with depression and thoughts of suicide by creating a personalized treatment plan that fits their needs and culture, making it easier for them to stick with their mental health care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | January 16, 2024 |
| Project end | November 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $202,882 |
| NIH project number | 5R34MH134915-02 |
| Project ID | NIH-11011441 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are racial and ethnic minoritized youth aged 12-18 who are experiencing symptoms of depression or are at risk for suicide.
✕Less likely to help
Patients who are not from racial or ethnic minority backgrounds or who do not exhibit symptoms of depression or suicide risk may not benefit from this research.
What this research studies
This research focuses on enhancing mental health treatment retention among racial and ethnic minoritized youth who are at risk for depression and suicide. It employs a measurement-based care approach, which uses patient-reported data to tailor treatment plans collaboratively, ensuring they are relevant and acceptable to the youth and their caregivers. The study aims to address the unique challenges faced by these youth, such as poor therapeutic alliances and concerns about treatment relevance. By developing a culturally-tailored intervention called Strategic Treatment Assessment for Youth (STAY), the research seeks to improve engagement and outcomes in mental health services.
Why it matters
Potential benefit: If successful, this research could lead to improved mental health outcomes and increased retention in treatment for minority youth facing depression and suicide risk.
How similar studies have gone: Previous research has shown that measurement-based care can effectively improve treatment engagement, but this specific approach tailored for racial and ethnic minoritized youth is novel.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Connors, Elizabeth Halsted — Yale University
- Study coordinator: Connors, Elizabeth Halsted
Related research
Other NIH-funded projects on the same topics.
-
Transdiagnostic Sleep and Circadian Treatment to Help Depression in Older Adults at Risk of Suicide
A new behavioral program for older adults with depression and high suicide risk aims to improve sleep and mood and reduce suicidal thoughts after treatment.
-
Imaging the brain's endocannabinoid system in young people with depression or suicidal behavior
The team will use PET brain scans to measure an enzyme that controls natural cannabis-like chemicals in teens and young adults with depression, some with past suicide attempts.
-
STAY: helping teens stay in care for depression or suicide risk using regular progress check-ins
This project uses regular patient-reported progress check-ins to make care more relevant and help teens with depression or suicide risk stay engaged in treatment.
-
Using a sleep and body‑clock treatment to lower depression and suicide risk in older adults
Seeing whether a behavioral program that stabilizes sleep and daily body clocks helps adults 21+ with moderate-to-severe depression who have active suicidal thoughts or a past suicide attempt.
-
Exploring how endocannabinoid metabolism relates to depression and suicide in young people
This study is looking at how a specific system in the body might affect feelings of sadness and thoughts of suicide in teens aged 12 to 20, focusing on a particular enzyme that could change how we feel and act, with the hope of finding new ways to help those struggling with these issues.
-
Using an AI assistant to screen for suicide, depression, and anxiety
This study is testing a new app called Clairity™ that uses smart technology to help spot signs of suicide, depression, and anxiety by listening to how people talk, making it easier for schools and healthcare providers to support those who might need help.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.